Amici for Sanofi Add Their Two Cents as Amgen’s Day in High Court Approaches

“Eli Lilly affirmed the Federal Circuit’s decision before the court, stating that ‘a claim like Amgen, which has no structural limitation and is limited only by functional consequences, cannot be used under § 112.’ I asked for explicit clarification that…








